-We have had problems with our email 1st July - 4th July. The problem is now solved.Please resend your emails!! Thanks!
Optimized MSC Growth Medium formulation with low serum content
GeneTex Incorporates Negative Controls into the Quality Assurance Process.
Antibodies are essential tools for both basic and clinical research. However, there has been growing distrust of commercially available antibodies with regard to specificity and performance variability. As a result, the research community and funding agencies have demanded that antibody suppliers increase their efforts to more thoroughly validate these reagents. One approach to address this is through knockdown or knockout of the target protein by RNAi- or CRISPR-mediated technologies.
In support of this goal, GeneTex is conducting knockdown-based validation as a fundamental component of its antibody quality assurance process. To date, we have evaluated over two hundred of our most popular products covering multiple research topics, such as apoptosis, metabolism, epithelial–mesenchymal transition, and neurodegenerative diseases. We will continue to expand these efforts in the future. Antibodies that have passed the KO/KD test will be labeled with the KO/KD validated icon.